Revvity RVTY Diagnostics — Segment Selling, general and administrative expenses

Similar metrics at other companies

LHDiagnostics — Other Cost and Expense, Operating

$438M+1.8%

ALife Sciences and Diagnostics Markets — Selling, General and Administrative Expense

$170M+8.3%

TEC

TECHDiagnostics And Spatial Biology — Selling General And Administrative Expense

$27.62M-17.4%

SPXCDetection and Measurement reportable segment — SG&A

$37.9M+4.7%

DGXDIS business — Less: Other segment items

$2.38B+9.2%

TEMDiagnostics — Cost of Goods Sold

$100.96M+19.1%

Questions, answered.

What is Revvity's diagnostics — segment selling, general and administrative expenses?

Revvity (RVTY) reported diagnostics — segment selling, general and administrative expenses of $90.19M in Q1 2026.

How has Revvity's diagnostics — segment selling, general and administrative expenses changed year-over-year?

Revvity's diagnostics — segment selling, general and administrative expenses increased by 0.3% year-over-year, from $89.89M to $90.19M.

What is the long-term trend for Revvity's diagnostics — segment selling, general and administrative expenses?

Over 3 years (2022 to 2025), Revvity's diagnostics — segment selling, general and administrative expenses has grown at a -4.9% compound annual growth rate (CAGR), from $399.55M to $343.43M.

What does diagnostics — segment selling, general and administrative expenses mean?

Operating expenses for the diagnostics segment excluding direct production costs and R&D.

How do you interpret diagnostics — segment selling, general and administrative expenses?

High SG&A as a percentage of revenue may indicate heavy investment in growth, while a downward trend suggests improved operational leverage.

How does diagnostics — segment selling, general and administrative expenses compare across companies?

Standard operating expense metric used across all industries to measure administrative and sales efficiency.